IPL 2020 will get underway from September 19 with its final being played on November 10. The lucrative tournament will be played for the second time in UAE. However, the fixtures are still to be confirmed, but it looks like Chennai Super Kings (CSK) will face off against Mumbai Indians in the inaugural contest.
The cricket board has released SOPs for the players, support staffs and families accompanying them to UAE to follow during the IPL. The Times of India has now reported that players will also have to undergo dope test which will be jointly conducted by the National Anti-Doping Agency (NADA) and UAE’s National Anti-Doping Committee (NADO).
The SOP which will be followed in UAE will also be of NADO’s as both in out-of-competition testing to be done as per the report. It will be made sure that it is a no-contact testing during this Covid-19 situation. The cost of testing each sample in Doha laboratory will be USD 350 which is an issue for NADA. The anti-doping watchdog of India, hence, might look to conduct only a limited number of tests.
“We will be conducting the dope testing at the IPL like any other BCCI event, following the health and safety protocols. We will be organising the DCOs trip, either from India or the UAE or both to the match venues.
NADA has discussed the issue with the UAE NADO and some amount of understanding has already been reached. We are waiting for the IPL governing council to finalise the tournament fixtures to plan accordingly,” NADA director general, Navin Agarwal, told TOI.
It will be the first time that such a procedure has been adapted. Earlier, in the IPL, a Sweden-based International Dope Test and Management (IDTM) that did the testing for cricketers .
Furthermore, NADA is also expecting more challenges as all the eight franchises will remain in the bio-bubble environment.